Panacea Index Logo

Command Palette

Search for a command to run...

The development and pilot randomised controlled trial of a group education programme for promoting walking in people with intermittent claudication.

Vascular medicine (London, England)
August 1, 2015
Garry A Tew et al. (9 authors)
Journal ArticleRandomized Controlled TrialResearch Support, Non-U.S. Gov'tHuman StudyClinical
Study Details

Study Goal

The researchers aimed to develop and evaluate a group education program to promote walking in people with intermittent claudication.

Results Summary

The intervention group showed superior walking capacity and quality of life compared to controls, with significant improvements in six-minute walk distance, treadmill maximum walking distance, and ICQ scores. Daily step counts did not differ between groups, and exit interviews indicated the program was well-received and increased participants' understanding of their condition and walking habits.

Population

People with intermittent claudication (Rutherford category 1-3).

Effective Dosage

Three-hour group-based education workshop plus follow-up telephone support.

Duration

Six weeks.

Interactions

None mentioned.

Extracted Claims (6)
InterventionDirectionEndpointPopulationDosageImpactClaim #
group education programme for promoting walking
increase
walking capacity
people with intermittent claudication (Rutherford category 1-3)
-
had superior
#1
group education programme for promoting walking
increase
quality of life
people with intermittent claudication (Rutherford category 1-3)
-
had superior
#2
group education programme for promoting walking
increase
six-minute walk distance
people with intermittent claudication (Rutherford category 1-3)
44.9 m (95% CI, 6.9 to 82.9)
mean difference
#3
group education programme for promoting walking
increase
treadmill maximum walking distance
people with intermittent claudication (Rutherford category 1-3)
173 m (95% CI, 23 to 322)
mean difference
#4
group education programme for promoting walking
decrease
Intermittent Claudication Questionnaire (ICQ) score
people with intermittent claudication (Rutherford category 1-3)
-10.6 (95% CI, -18.9 to -2.3)
mean difference
#5
group education programme for promoting walking
no change
daily step count
people with intermittent claudication (Rutherford category 1-3)
-
did not differ
#6
Abstract

UNLABELLED: The aim of this study was to develop and pilot a group education programme for promoting walking in people with intermittent claudication. Patient focus groups (n=24) and literature reviews were conducted to inform the development of the education programme, which involves a three-hour group-based education workshop and follow-up telephone support. A pilot study was subsequently conducted in which 23 new patients (Rutherford category 1-3) were randomly assigned to usual care (control) or usual care plus the education programme. Outcomes were assessed at baseline and six weeks including daily steps (tri-axial accelerometer), walking capacity (six-minute walk test and Gardner treadmill test), and quality of life (Intermittent Claudication Questionnaire [ICQ]). Exit interviews were conducted to assess the acceptability and usefulness of the programme. Compared with controls, the intervention group had superior walking capacity and quality of life at six weeks. Mean differences in six-minute walk distance, treadmill maximum walking distance and ICQ score were 44.9 m (95% confidence interval [CI], 6.9 to 82.9), 173 m (95% CI, 23 to 322), and -10.6 (95% CI, -18.9 to -2.3), respectively. The daily step count did not differ between groups. The exit interviews indicated that participants valued attending the programme, that it gave them a greater understanding of their condition, and that they had been walking more for exercise since attending. The results suggest that the education programme is feasible, acceptable, and potentially useful for improving walking capacity and quality of life. A fully-powered trial exploring clinical and cost effectiveness is needed. TRIAL REGISTRATION NUMBER: ISRCTN06733130 (http://www.controlled-trials.com).

Medical Subject Headings (MeSH)
ActigraphyAgedAged, 80 and overEnglandExercise TestExercise TherapyFeasibility StudiesFemaleGroup ProcessesHealth Knowledge, Attitudes, PracticeHumansIntermittent ClaudicationInterviews as TopicMaleMiddle AgedPatient CompliancePatient Education as TopicPatient SatisfactionPeripheral Arterial DiseasePilot ProjectsProgram DevelopmentProgram EvaluationState MedicineTelephoneTime FactorsTreatment OutcomeWalking
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations36
Citations/Year3.6
Relative Citation Ratio1.84
NIH Percentile71.9%
Research Impact Scores
APT Score0.75
Weight Score1.82
Normalized Score0.66
Related Supplements